Alzheimer's Disease
Showing NaN - NaN of 79
Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)
Terminated
- Alzheimer's Disease
- Behavioral Variant Frontotemporal Dementia
-
Phoenix, Arizona
- +134 more
May 15, 2020
Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)
Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)
Terminated
- Alzheimer's Disease
- Group 1 ELND005
- Group 2 ELND005
-
Birmingham, Alabama
- +45 more
Oct 17, 2019
Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))
Completed
- Alzheimer's Disease
- ELND005 (scyllo-inositol)
-
Phoenix, Arizona
- +37 more
Oct 17, 2019
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)
Completed
- Alzheimer's Disease
- Idalopirdine 60 mg
-
Birmingham, Alabama
- +257 more
Aug 9, 2018
Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)
Completed
- Alzheimer's Disease
- Bryostatin 1
- Placebo
-
Phoenix, Arizona
- +28 more
Jun 6, 2018
Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 150 mg/day
- +2 more
-
Phoenix, Arizona
- +120 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)
Completed
- Alzheimer's Disease
- TRx0237 200 mg/day
- Placebo
-
Phoenix, Arizona
- +94 more
Mar 12, 2018
Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)
Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone Extended Release 2mg
- +3 more
-
Litchfield Park, Arizona
- +248 more
Oct 23, 2017
Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)
Terminated
- Alzheimer's Disease
- Rosiglitazone XR
-
Litchfield Park, Arizona
- +271 more
Oct 11, 2017
Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)
Completed
- Alzheimer's Disease
- Rosiglitazone Extended Release 2mg
- +2 more
-
Sun City, Arizona
- +193 more
Aug 3, 2017
Alzheimer's Disease Trial in Worldwide (PF-05212377 (SAM-760), Placebo)
Terminated
- Alzheimer's Disease
- PF-05212377 (SAM-760)
- Placebo
-
Costa Mesa, California
- +59 more
Jan 30, 2017